Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
The Environmental Determinants of Diabetes in the Young (TEDDY) Research Initiative CDC NIDDK, NIAID, NICHD, NIEHS This consortium is organizing international efforts to identify infectious agents, dietary factors, or other environmental factors that trigger type 1 diabetes in genetically susceptible people. The study enrolled over 8,000 newborns and is following them for 15 years to identify environmental triggers of type 1 diabetes.
The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM) Research Initiative CDC NCI EMBLEM provides a unique infrastructure to obtain valuable data and samples to study Burkitt’s lymphoma (BL) epidemiology. Study data will help characterize or investigate: 1. The association of malaria-resistance genes with endemic BL. 2. Host genetic polymorphisms associated with BL using genome-wide association methods. 3. The role of the Epstein-Barr virus (EBV) genetic variants in endemic BL. 4. The role of malaria immunology and phenotype of inflammation in BL. 5. The complexity of coinfection with different P. falciparum malaria genotypes in BL. 6. The interaction between helminthic parasites, HIV, malaria, and EBV in BL. 7. The immunohistochemistry and molecular pathology of BL. 8. The impact of malaria, helminthic parasites, and HIV on childhood BL.
The Federal Tuberculosis Task Force Committee, Work group, Advisory group, or Task Force AHRQ, CDC, FDA, HRSA, IHS, OS NIAID The Federal Tuberculosis (TB) Task Force is a coalition composed of the Federal agencies and organizations involved in U.S. TB control efforts. Established in 1991, the Task Force facilitates coordination of activities between Federal agencies. It was created by the Director of the Centers for Disease Control and Prevention (CDC) to address the outbreaks of multidrug-resistant (MDR) TB occurring during the 1985-1992 surge in TB cases. The TB Task Force is co-chaired by CDC and NIAID.
The Healthy Brain Initiative Public Education Campaign ACL, CDC NIA A call to action and a guide to assist in implementing a coordinated approach to moving cognitive health into public health practice.
The Impact of Tobacco Use on Oral Health and the Oral Microbiome Research Initiative CDC, FDA NCI U.S. Food and Drug Administration Intramural Center of Tobacco Regulatory Science Award Program funded a project examining how tobacco affects oral health and the oral microbiome in the National Health and Nutrition Examination Survey (NHANES) study.
The Incidence of Breast and Other Cancers Among Female Flight Attendants Research Initiative CDC NCI A cohort study of approximately 10,000 Pan Am flight attendants to determine cancer incidence (primarily breast cancer) associated with cosmic radiation and circadian disruption from their work.
The Interagency Committee on Human Nutrition Research (ICHNR) Other CDC, FDA NIDDK The Interagency Committee on Human Nutrition Research (ICHNR) provides a mechanism for communicating among the various Federal agencies to enhance the coordination of human nutrition research activities.
The Intersection of Violence and HIV Risk in Women Working Group Committee, Work group, Advisory group, or Task Force ACF, CDC, FDA, HRSA, IHS, OS OD/DPCPSI/OAR This Working Group established to address the research issues on violence and HIV in women including research gaps, current knowledge and current interventions. The Working Group conducted meetings separately and together with the White House Working Group in which they provided information and recommendations to the White House Violence against Women and HIV Initiative.
The Middle East Respiratory Syndrome (MERS) Therapeutics Working Group Committee, Work group, Advisory group, or Task Force CDC, FDA, OS NIAID The Middle East Respiratory Syndrome (MERS) Therapeutic Working Group was established by the Assistant Secretary for Preparedness and Response (ASPR) to coordinate the Department of Health and Human Services (HHS) response to therapeutics development for the MERS outbreak of 2012-2013.
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee Committee, Work group, Advisory group, or Task Force CDC, FDA NCI, NIBIB, OD/OSP This subcommittee of the National Science and Technology Council''s Committee on Technology is responsible for coordinating the National Nanotechnology Initiative (NNI). The NNI was established in 2001 to coordinate federal research and development in nanotechnology by providing a vision of the long-term benefits and opportunities offered by nanotechnology and acting as a locus for communication, cooperation, and collaboration between federal agencies involved in nanotechnology research and development. In 2011, the NSET developed a strategic plan that encompasses a comprehensive nanotechnology R&D initiative built on shared goals, priorities, and strategies that complement agency-specific missions and activities.